e.verhoeven

TL2 · Tours

Contributes reviews on supplier material. Based in Tours.

Joined 17 August 2025 · last posted 9h

74 posts, newest first. Showing up to 150.

Follow-up: Comparing two chromatograms from different laboratories, properly Replied, post #68 · Analytics › HPLC & UHPLC · 28 Jul 2026 · 33 likes Area percent is a proportion of absorbance, not a proportion of mass. Two species with different extinction coefficients at the detection wavelength contribute…
Stepping down deliberately, and how to do it without losing progress — what changed since Replied, post #92 · Practice › Dosing & titration · 24 Jul 2026 · 0 likes I came in to disagree and I am leaving without a disagreement.
Prior authorisation: what the criteria usually require — a second dataset Replied, post #33 · Access › Insurance & coverage · 16 Jul 2026 · 0 likes That reframing is the whole thing. The facts I already had.
Common supplements people ask about, assessed one at a time Replied, post #51 · Practice › Interactions · 15 Jul 2026 · 17 likes Picking up post #48: that is the part I would want checked first. Whatever the answer on common supplements turns out to be, the method for getting there is the same:…
What I would want from a home test that does not exist yet Replied, post #38 · Analytics › Home & field testing · 15 Jul 2026 · 0 likes Photographs of test results posted here are worth including with the lighting and the timing stated, because both change the apparent result of a colorimetric method…
Journal club: SUSTAIN 6 and its retinopathy signal Replied, post #35 · Evidence › Journal club · 7 Jul 2026 · 3 likes Adding what did not work for me on SUSTAIN 6, since the failures never get written up and they are half the useful information.
Journal club: what we got wrong in an earlier session Replied, post #62 · Evidence › Journal club · 7 Jul 2026 · 23 likes Sessions on negative or null results are consistently the most instructive and the hardest to get anyone to attend.
Personal or family history of medullary thyroid carcinoma — what changed since Replied, post #92 · Safety › Contraindications · 29 Jun 2026 · 0 likes Allergy to the specific compound: true allergy is rare but possible. Any prior allergic reaction to the same compound or to structurally similar peptides warrants…
Journal club: orforglipron phase 2 and the non-peptide question Replied, post #101 · Evidence › Journal club · 24 Jun 2026 · 1 like Adding the measurement that post #100 says would settle it. Orforglipron phase 2 has been discussed here with more heat than it deserves, mostly because two definitions…
Semaglutide and gastric emptying — the mechanism behind most of the side-effect profile Replied, post #68 · Compounds › Semaglutide · 18 Jun 2026 · 1 like The opalescent appearance in semaglutide solutions is occasionally noted and the mechanism is unclear. It does not appear to correlate with product failure in practice.…
Revisiting: Can a home kit substitute for a laboratory report? A careful no Replied, post #36 · Analytics › Home & field testing · 17 Jun 2026 · 22 likes Coming back to post #32, because the follow-up matters more than the original answer. What you can use home tests for: confirmation that a solution contains peptide (as…
A reconstituted vial's beyond-use date and the reasoning behind common figures Replied, post #112 · Practice › Storage & stability · 9 Jun 2026 · 0 likes Post #110 and I disagree about the size of the effect, not about the direction. Distinguishing three things in the reconstituted discussion that keep getting used…
Shakes versus food: a pragmatic assessment Replied, post #15 · Nutrition & Training › Protein & intake · 8 Jun 2026 · 3 likes Narrowing post #14, because the general version has more than one answer. Liquid sources are tolerated better than solid ones by many people here, and that is a…
Pooling trials with different estimands Replied, post #10 · Evidence › Meta-analyses · 6 Jun 2026 · 19 likes Following, with nothing to contribute beyond having asked the same thing elsewhere.
Follow-up: A parcel that arrived warm: a decision process, not a verdict Replied, post #58 · Practice › Storage & stability · 5 Jun 2026 · 5 likes Visible particulate is a strong signal in the other direction: it is a reason to stop and ask rather than to filter and proceed. I have separated what I observed from…
Follow-up: Tirzepatide and nausea: is the profile genuinely different or just… Replied, post #113 · Compounds › Tirzepatide · 1 Jun 2026 · 26 likes Following, with nothing to contribute beyond having asked the same thing elsewhere.
Revisiting: Journal club: SURMOUNT-OSA and a hard endpoint in a soft field Replied, post #8 · Evidence › Journal club · 30 May 2026 · 9 likes The claim about SURMOUNT-OSA upthread is stronger than its source supports. I have read the source. The source says "associated with" and the post says "causes".
Gastro-oesophageal reflux: improving or worsening? Replied, post #49 · Clinical › Comorbidities · 26 May 2026 · 12 likes Worth separating two things that post #45 runs together. The practical value of this subcategory is helping somebody frame the question they take to an appointment, and…
Reconstitution volumes that produce round numbers, tabulated Replied, post #111 · Practice › Reconstitution · 9 May 2026 · 3 likes Do not shake. Swirl, or leave it. Vigorous agitation introduces air and shear, and neither helps a peptide go into solution any faster than patience does.
Follow-up: Sleep quality changes during weight loss Replied, post #14 · Wellbeing › Sleep · 1 May 2026 · 0 likes Stimulants and sleep: if supplementing with caffeine or other stimulants for energy during weight loss, timing and dose matter for sleep. Evening stimulant use…
Second pass at: Where impurities in solid-phase peptide synthesis come from Replied, post #3 · Analytics › Impurities & related substances · 29 Apr 2026 · 0 likes Acetate content: counter-ion content. Trifluoroacetate or acetate from the salt form of the peptide. Affects mass calculations and should be stated on a complete…
Review: a draft on reconstitution arithmetic, with objections — one year on Replied, post #5 · Documentation › Doc review · 26 Apr 2026 · 16 likes The four criteria are that the question recurs, that the content is correct and sourced or labelled as community practice, that somebody will be named as maintainer…
Journal club: SURMOUNT-4 and continuation versus withdrawal Replied, post #33 · Evidence › Journal club · 19 Apr 2026 · 32 likes The version of SURMOUNT-4 and continuation versus withdrawal that I was taught turned out to be a teaching simplification. Useful, and not true in the way I had assumed…
Follow-up: I have no scientific background — can I still follow the analytics categories? Replied, post #9 · Start Here › Welcome · 17 Apr 2026 · 25 likes Nobody is going to check your credentials and nobody is going to ask. What gets asked for is the basis of a claim, which is a different thing and applies equally to…
[2026 update] 0.3 mL versus 0.5 mL versus 1 mL barrels: resolution matters Replied, post #34 · Devices › Syringes & needles · 16 Apr 2026 · 25 likes U-100 means the barrel is graduated for a solution containing one hundred units of insulin per millilitre. For anything that is not insulin, the units are simply…
Follow-up: State-level differences that actually matter Replied, post #86 · Regional › North America · 8 Apr 2026 · 7 likes Picking up post #85: that is the part I would want checked first. The confident answers on State-level differences and the well-sourced answers are not the same…
Journal club: orforglipron phase 2 and the non-peptide question Replied, post #29 · Evidence › Journal club · 2 Apr 2026 · 17 likes Orforglipron phase 2 sits at the boundary between what this community can usefully discuss and what it cannot, and I think it falls on the discussable side, narrowly.
Choosing which test to pay for, given a fixed budget Replied, post #45 · Sourcing › Independent verification · 29 Mar 2026 · 2 likes Repeat determination on the same product line months apart is the measurement that speaks to consistency, and consistency is what most buyers actually want. Take it as…
A site rotation scheme that is easy enough to actually follow Replied, post #27 · Practice › Administration · 25 Mar 2026 · 27 likes Site reactions that appear immediately and settle within a day are described commonly here. Ones that appear a day later and spread are a different observation and…
Grapefruit: why this class is not the class that cares Replied, post #42 · Practice › Interactions · 15 Mar 2026 · 3 likes The most defensible general position in this subcategory: identify the plausible mechanism, check whether it has been studied, and where it has not, say that rather…
Price changes over 2025 and 2026, tabulated and dated — does this still hold? Replied, post #95 · Access › Pricing · 21 Feb 2026 · 9 likes Post #94 is right about the mechanism and I think understates the practical bit. A price well below the rest of the market is a fact rather than a finding, and it is…
Storing lyophilised material long term: what governs the shelf life Replied, post #69 · Practice › Storage & stability · 17 Feb 2026 · 1 like Visible particulate is a strong signal in the other direction: it is a reason to stop and ask rather than to filter and proceed.
MHRA statements, read directly Replied, post #85 · Regional › UK & Ireland · 9 Feb 2026 · 27 likes What I want from this MHRA statements thread is the list of things that would need to be true for the claim to hold. If we can write that list, we can check it.
Cost per delivered dose, which is the number that matters Replied, post #32 · Access › Pricing · 22 Dec 2025 · 3 likes Nothing here is financial advice and none of it is a route to a transaction.
Prescription requirements and telehealth models Replied, post #80 · Sourcing › Regulatory · 20 Dec 2025 · 1 like Generic or biosimilar entry depends on patent and exclusivity positions that are jurisdiction-specific and are frequently misreported.
Warfarin and altered intake: the monitoring argument — the long version Replied, post #71 · Practice › Interactions · 18 Dec 2025 · 0 likes Worth separating Warfarin and altered intake as a question about the compound from Warfarin and altered intake as a question about the documentation. They get answered…
Publishing an inconvenient result: a case study — the long version Replied, post #52 · Sourcing › Independent verification · 28 Nov 2025 · 26 likes Practical answer on Publishing an inconvenient result, since the theoretical one is upthread: do the simplest check first, write down the result, and only then decide…
Half-life, steady state, and accumulation worked through — a second dataset Replied, post #21 · Pharmacology › Pharmacokinetics · 17 Nov 2025 · 9 likes Noted, and I have changed what I was going to do on the strength of it.
Pharmaceutical compounding rules, summarised from primary sources — a second dataset Replied, post #35 · Sourcing › Regulatory · 17 Nov 2025 · 9 likes Adding the boring version of Pharmaceutical compounding rules, because the interesting version keeps getting posted and the boring one is usually right. Check the…
Can a home kit substitute for a laboratory report? A careful no Replied, post #47 · Analytics › Home & field testing · 6 Nov 2025 · 5 likes Reagent shelf life is a real constraint on kits and is frequently ignored. An old kit fails in the direction of a false negative more often than the reverse. Written in…
Amylin receptor signalling and satiety Replied, post #21 · Pharmacology › Receptor biology · 31 Oct 2025 · 19 likes An update on my earlier amylin receptor signalling and satiety post: the pattern held for another six weeks and then stopped, which I did not predict and cannot explain.
"Greater than or equal to 99%" as a specification rather than a result Replied, post #55 · Analytics › COA interpretation · 19 Oct 2025 · 0 likes Taking post #53 at face value and following it one step further. A chromatogram supplied as a small image is legible for peak shape and not for baseline detail. That is…
Coming back to: Over-dilution: when your dose falls below one readable graduation Replied, post #67 · Practice › Reconstitution · 12 Oct 2025 · 3 likes Post #65 and I disagree about the size of the effect, not about the direction. Do not shake. Swirl, or leave it. Vigorous agitation introduces air and shear, and…
Follow-up: Why the titration planner refuses to produce a schedule below a floor Replied, post #147 · Data & Tools › Calculators · 11 Oct 2025 · 0 likes Practical note on titration planner refuses: write down what you expect before you look. The number of times I have found what I went looking for is higher than chance…
Reporting a disappointing outcome, and why it belongs here Replied, post #28 · Outcomes › Progress reports · 12 Sep 2025 · 0 likes Adding the measurement that post #25 says would settle it. The reason reporting a disappointing outcome keeps being re-asked is that the answer is conditional and…
Revisiting: Reading a denial letter as a specification for your appeal Replied, post #104 · Access › Insurance & coverage · 2 Sep 2025 · 0 likes That matches what I have seen, for whatever a single anecdote is worth.
When a preprint is the best available evidence and we say so Replied, post #36 · Evidence › Preprints · 8 Aug 2025 · 4 likes Confirming post #34 from a second method, which matters more than confirming it from a second person. Server repositories: medRxiv for medicine, bioRxiv for biology.…
What I would record differently if I started again — the long version Replied, post #4 · Outcomes › Progress reports · 10 Jul 2025 · 0 likes Maintenance series are the ones this subcategory needs most and receives least. The interesting questions all change once loss stops. The variance between people here…
[2026 update] An appeal that failed, and what I would do differently Replied, post #73 · Access › Insurance & coverage · 12 Jun 2025 · 6 likes Keep every document with dates in one place. An appeal months later is assembled from whatever you kept. Where I would look next, rather than where I would stop.
Journal club: SURMOUNT-1, read without the press release Replied, post #129 · Evidence › Journal club · 2 Jun 2025 · 0 likes I changed my mind about SURMOUNT-1 after someone here asked me for the source and I could not produce one. That is worth saying out loud because it is the ordinary way…
Half-life, steady state, and accumulation worked through Replied, post #46 · Pharmacology › Pharmacokinetics · 31 May 2025 · 0 likes The most useful reply I ever got about half-life was a request to state my units. It sounds like pedantry and it has saved me twice.
Second pass at: Designing a personal experiment that could change your mind Replied, post #32 · Research Methods › N-of-1 designs · 20 May 2025 · 32 likes Write down what you would accept as evidence that it did not work, before starting. That one sentence turns an anecdote into an experiment.
Pregnancy as an absolute contraindication Replied, post #93 · Safety › Contraindications · 20 May 2025 · 2 likes Labelling differs between jurisdictions for the same molecule, so quoting a contraindication should say which document it comes from.
DXA precision and the least significant change for lean mass — the long version Replied, post #53 · Outcomes › Body composition · 17 May 2025 · 33 likes Noted, and thank you for writing it out rather than summarising it.
Research-use-only labelling: what it means and what it does not — the long version Replied, post #149 · Sourcing › Regulatory · 10 May 2025 · 5 likes I read post #146 twice before replying, because I had assumed the opposite. Research-use-only status is a legal classification, not a safety classification. It means…
How Janoshik, Medutest, PeptideMeter and VendorInvestigate differ Replied, post #54 · Sourcing › Independent verification · 6 May 2025 · 18 likes Post #52 put the caveat in the right place and I want to underline it. Medutest: combined purity and identity reporting. Appears throughout vendor documentation. Where…
Follow-up: Documentation that appears only after payment Replied, post #27 · Sourcing › Red flags · 27 Apr 2025 · 2 likes Bookmarking this. I will come back when I have something worth adding.
Journal club: STEP 1 and the treatment-policy estimand — does this still hold? Replied, post #91 · Evidence › Journal club · 21 Apr 2025 · 26 likes The most common failure mode is spending fifty minutes on the effect size and ten on the population. Reversing that ratio would improve most sessions. This is the sort…
Journal club: STEP 1 and the treatment-policy estimand — does this still hold? Replied, post #72 · Evidence › Journal club · 20 Apr 2025 · 28 likes Understood, and I withdraw the assumption I opened with.
Follow-up: What other technical communities get right that we do not Replied, post #63 · Lounge › Off topic · 10 Apr 2025 · 0 likes Lounge question, no agenda: does anyone else keep a physical notebook for this rather than a file? Mine is more use than anything I have typed, and I cannot entirely…
A 5 mg vial and a 0.25 mg dose: the arithmetic in full — what changed since Replied, post #47 · Practice › Reconstitution · 9 Apr 2025 · 3 likes Write the reconstitution date and the concentration on the vial. Not on a note, on the vial. Every account here of a dosing error involving the wrong concentration…
A page that has drifted out of date and needs a maintainer Replied, post #87 · Documentation › Wiki requests · 9 Apr 2025 · 0 likes Right, and stated more narrowly than I would have dared to state it.
Units, standards, and other things that quietly hold the world together Replied, post #15 · Lounge › Off topic · 9 Apr 2025 · 18 likes I have three months of notes on units and the honest summary is that the trend is real and the week-to-week numbers are noise. I nearly drew the opposite conclusion…
SNAC and the mechanism of oral peptide absorption Replied, post #14 · Compounds › Oral incretins · 25 Feb 2025 · 3 likes On analysis of a small molecule: purity by chromatography against a reference standard, identity by mass and by spectroscopy, and residual solvents by a headspace…
Reporting a disappointing outcome, and why it belongs here Replied, post #5 · Outcomes › Progress reports · 21 Feb 2025 · 16 likes A single scale used throughout beats a more accurate scale introduced halfway through. Consistency beats accuracy for a trend. Someone will know this better than I do…
Revisiting: Aggregate verification data across the directory, with caveats Replied, post #8 · Sourcing › Independent verification · 14 Feb 2025 · 31 likes Interpreting a result: a purity figure is one measurement on one vial on one day. Agreement across two services is much stronger. A single high number does not…
Protein density versus volume when you cannot eat much Replied, post #16 · Nutrition & Training › Protein & intake · 25 Jan 2025 · 0 likes Reading back through the protein density versus volume threads from last year, the same three questions come up every time and only one of them has ever been answered…
Escalating every six weeks instead of four: what I observed over eight months — one year… Replied, post #4 · Practice › Dosing & titration · 15 Jan 2025 · 31 likes Answering the question the opening post raises rather than the one it answers. Reaching a dose and staying there for a year: the question of whether a stable dose…
Molecular mass of semaglutide and why the figure differs between sources — does this… Replied, post #4 · Compounds › Semaglutide · 17 Dec 2024 · 2 likes On post #2 — agreed on the reasoning, with one qualification. Adding a reference point for Molecular mass of semaglutide. Mine is a single case, collected without…
Journal club: SUSTAIN 6 and its retinopathy signal — does this still hold? Replied, post #9 · Evidence › Journal club · 3 Dec 2024 · 10 likes Where I part company with post #8, and it is a narrow parting. Practical note on SUSTAIN 6: write down what you expect before you look. The number of times I have found…
Second pass at: A field-by-field walk through a certificate of analysis Replied, post #123 · Analytics › COA interpretation · 20 Nov 2024 · 8 likes Taking post #122 at face value and following it one step further. The failure mode on field-by-field walk through a certificate is boring rather than dramatic. It is…
Requesting a page: what makes a good request — what changed since Replied, post #139 · Documentation › Wiki requests · 13 Oct 2024 · 30 likes Post #138 answers the question as asked. The question underneath it is different. A request that says what the page should not cover is unusually helpful, because scope…
Identical chromatograms across two different lots Replied, post #22 · Sourcing › Red flags · 5 Sep 2024 · 14 likes Nothing here should be read as an accusation against a named company, and the guidelines exist so that reports remain reports.
Cold packs, phase-change material, and what survives ten days Replied, post #101 · Sourcing › Logistics · 13 Jul 2024 · 22 likes Small correction to my own earlier position on cold packs. I had the units the wrong way round, which changes the conclusion by an order of magnitude and therefore…